Trials / Terminated
TerminatedNCT00930072
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Safety and Efficacy of Cervical Sympathetic Block in Patients With Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage - Pilot Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cervical Sympathetic Block (bupivicaine, clonidine) | 12-15ml solution of bupivicaine .5% containing 50 mcg of clonidine for cervical sympathetic block administered in a single injection. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2009-06-30
- Last updated
- 2017-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00930072. Inclusion in this directory is not an endorsement.